The HOME Network Website
  • HOME
    • Members
  • About Us
    • Our History
    • Organisational Structure
    • Focus Areas and Objectives
    • Strategic Plan
    • Our Partners & Sponsors
  • Our Work
    • Current Projects >
      • TEACH-PD
    • Year at a Glance >
      • 10 Year Anniversary
      • Major Achievements 2017-2018
      • Major Achievements in 2016
      • Major Achievements in 2015
      • Major Achievements In 2014
      • Major Achievements 2012-2013
  • Patient Information
  • Resources
    • Resources for Healthcare Professionals >
      • The HOME Network TelEhealth & Remote Monitoring Start-up Tool Kit (THN-TERMS)
    • Publications and Newsletters
  • Contact Us

Targeted Education ApproaCH to improve Peritoneal Dialysis Outcomes (TEACH-PD)

​TEACH-PD Pilot

TEACH-PD Cluster Randomised Trial
Picture
TEACH-PD Update - A Targeted Education Approach to improve Peritoneal Dialysis Outcomes (TEACH-PD)
Co-Principal Investigator: Professor Josephine Chow & Professor Neil Boudville
Lead, THN Healthcare Professional Education Group: Melinda Tomlins
TEACH-PD CRCT commenced in Australia in September 2019 and New Zealand in February 2020

Picture
A pragmatic, multi-centre, multinational, registry-based, cluster-randomised trial (CRCT), randomising PD units to implementing TEACH-PD training modules targeted at PD trainers and incident PD patients versus standard existing practices.
The TEACH-PD training curriculum and material have been developed by a core group of renal nurses from The HOME Network (THN) in conjunction with senior medical clinicians from the Australasian Kidney Trials Network (AKTN), eLearning curriculum developers, consumer representatives, and education experts, in line with the ISPD guidelines, utilising modern adult learning principles and best practice eLearning techniques.
The COVID-19 pandemic has presented unique challenges for the TEACH-PD trial community; being temporarily paused early 2020, the recruitment has been recommenced in full since May 2020.  The trial team has adopted strategies in keeping with a proportionate approach to risk assessment, virtual induction and site activation, and remote monitoring.  The trial is integrated into usual clinical practice and no additional face-to-face study visits are required.  Follow-up of the enrolled participants is unlikely to be affected by the COVID-19 pandemic.

Picture
Our Legal Terms & Privacy Policy
The HOME NetworkTM 2014
Powered by Create your own unique website with customizable templates.